APO Research
Talk to an analyst

APO RESEARCH · REPORT

Abortion Medication

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Abortion Medication Industry Growth and Trends Forecast to 2032

23 December 202597 pages

Choose your research edition.

Industry ResearchAbortion Medication Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Abortion Medication Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Abortion Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Abortion Medication Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Abortion Medication Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Abortion Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Abortion Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Abortion Medication is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Abortion Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Abortion Medication include Cadila, Cipla, Exelgyn Laboratories, GenBioPro, Zizhu-pharm, Shanghai Xinhualian Pharmaceutical Co., Ltd and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Abortion Medication market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Abortion Medication market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Abortion Medication market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Abortion Medication.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Abortion Medication market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Abortion Medication Market by Company

Cadila

Cipla

Exelgyn Laboratories

GenBioPro

Zizhu-pharm

Shanghai Xinhualian Pharmaceutical Co., Ltd

Sun Pharma

Abortion Medication Segment by Type

Mifepristone

Misoprostol

Abortion Medication Segment by Application

Clinic

Hospital

Others

Abortion Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Abortion Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Abortion Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Abortion Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Abortion Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Abortion Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Mifepristone Table 2. Major Company of Misoprostol Table 3. Global Abortion Medication Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Abortion Medication Sales by Type (2021-2026) & (k units) Table 5. Global Abortion Medication Sales Market Share in Volume by Type (2021-2026) Table 6. Global Abortion Medication Sales by Type (2021-2026) & (US$ Million) Table 7. Global Abortion Medication Sales Market Share in Value by Type (2021-2026) Table 8. Global Abortion Medication Price by Type (2021-2026) & (USD/unit) Table 9. Global Abortion Medication Sales by Type (2027-2032) & (k units) Table 10. Global Abortion Medication Sales Market Share in Volume by Type (2027-2032) Table 11. Global Abortion Medication Sales by Type (2027-2032) & (US$ Million) Table 12. Global Abortion Medication Sales Market Share in Value by Type (2027-2032) Table 13. Global Abortion Medication Price by Type (2027-2032) & (USD/unit) Table 14. North America Abortion Medication Sales by Type (2021-2026) & (k units) Table 15. North America Abortion Medication Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Abortion Medication Sales by Type (2021-2026) & (k units) Table 17. Europe Abortion Medication Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Abortion Medication Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Abortion Medication Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Abortion Medication Sales by Type (2021-2026) & (k units) Table 21. Latin America Abortion Medication Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Abortion Medication Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Abortion Medication Sales by Type (2021-2026) & (US$ Million) Table 24. Abortion Medication Industry Trends Table 25. Abortion Medication Industry Drivers Table 26. Abortion Medication Industry Opportunities and Challenges Table 27. Abortion Medication Industry Restraints Table 28. Global Abortion Medication Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Abortion Medication Revenue Market Share by Company (2021-2026) Table 30. Global Abortion Medication Sales by Company (2021-2026) & (k units) Table 31. Global Abortion Medication Sales Share by Company (2021-2026) Table 32. Global Abortion Medication Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Abortion Medication Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Abortion Medication Major Company Production Sites and Headquarters Table 35. Global Abortion Medication Company, Product Type & Application Table 36. Global Abortion Medication Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Abortion Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Abortion Medication Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Abortion Medication Sales by Region (2021-2026) & (k units) Table 41. Global Abortion Medication Sales Market Share in Volume by Region (2021-2026) Table 42. Global Abortion Medication Sales by Region (2021-2026) & (US$ Million) Table 43. Global Abortion Medication Sales Market Share in Value by Region (2021-2026) Table 44. Global Abortion Medication Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Abortion Medication Sales by Region (2027-2032) & (k units) Table 46. Global Abortion Medication Sales Market Share in Volume by Region (2027-2032) Table 47. Global Abortion Medication Sales by Region (2027-2032) & (US$ Million) Table 48. Global Abortion Medication Sales Market Share in Value by Region (2027-2032) Table 49. Global Abortion Medication Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Abortion Medication Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Abortion Medication Sales by Application (2021-2026) & (k units) Table 52. Global Abortion Medication Sales Market Share in Volume by Application (2021-2026) Table 53. Global Abortion Medication Sales by Application (2021-2026) & (US$ Million) Table 54. Global Abortion Medication Sales Market Share in Value by Application (2021-2026) Table 55. Global Abortion Medication Price by Application (2021-2026) & (USD/unit) Table 56. Global Abortion Medication Sales by Application (2027-2032) & (k units) Table 57. Global Abortion Medication Sales Market Share in Volume by Application (2027-2032) Table 58. Global Abortion Medication Sales by Application (2027-2032) & (US$ Million) Table 59. Global Abortion Medication Sales Market Share in Value by Application (2027-2032) Table 60. Global Abortion Medication Price by Application (2027-2032) & (USD/unit) Table 61. North America Abortion Medication Sales by Application (2021-2026) & (k units) Table 62. North America Abortion Medication Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Abortion Medication Sales by Application (2021-2026) & (k units) Table 64. Europe Abortion Medication Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Abortion Medication Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Abortion Medication Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Abortion Medication Sales by Application (2021-2026) & (k units) Table 68. Latin America Abortion Medication Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Abortion Medication Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Abortion Medication Sales by Application (2021-2026) & (US$ Million) Table 71. Cadila Company Information Table 72. Cadila Business Overview Table 73. Cadila Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Cadila Abortion Medication Product Portfolio Table 75. Cadila Recent Development Table 76. Cipla Company Information Table 77. Cipla Business Overview Table 78. Cipla Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Cipla Abortion Medication Product Portfolio Table 80. Cipla Recent Development Table 81. Exelgyn Laboratories Company Information Table 82. Exelgyn Laboratories Business Overview Table 83. Exelgyn Laboratories Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Exelgyn Laboratories Abortion Medication Product Portfolio Table 85. Exelgyn Laboratories Recent Development Table 86. GenBioPro Company Information Table 87. GenBioPro Business Overview Table 88. GenBioPro Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. GenBioPro Abortion Medication Product Portfolio Table 90. GenBioPro Recent Development Table 91. Zizhu-pharm Company Information Table 92. Zizhu-pharm Business Overview Table 93. Zizhu-pharm Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Zizhu-pharm Abortion Medication Product Portfolio Table 95. Zizhu-pharm Recent Development Table 96. Shanghai Xinhualian Pharmaceutical Co., Ltd Company Information Table 97. Shanghai Xinhualian Pharmaceutical Co., Ltd Business Overview Table 98. Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Product Portfolio Table 100. Shanghai Xinhualian Pharmaceutical Co., Ltd Recent Development Table 101. Sun Pharma Company Information Table 102. Sun Pharma Business Overview Table 103. Sun Pharma Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Sun Pharma Abortion Medication Product Portfolio Table 105. Sun Pharma Recent Development Table 106. North America Abortion Medication Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Abortion Medication Sales by Country (2021-2026) & (k units) Table 108. North America Abortion Medication Sales Market Share by Country (2021-2026) Table 109. North America Abortion Medication Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Abortion Medication Sales Market Share Forecast by Country (2027-2032) Table 111. North America Abortion Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Abortion Medication Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Abortion Medication Market Share by Country (2021-2026) Table 114. North America Abortion Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Abortion Medication Market Share Forecast by Country (2027-2032) Table 116. Europe Abortion Medication Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Abortion Medication Sales by Country (2021-2026) & (k units) Table 118. Europe Abortion Medication Sales Market Share by Country (2021-2026) Table 119. Europe Abortion Medication Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Abortion Medication Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Abortion Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Abortion Medication Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Abortion Medication Market Share by Country (2021-2026) Table 124. Europe Abortion Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Abortion Medication Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Abortion Medication Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Abortion Medication Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Abortion Medication Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Abortion Medication Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Abortion Medication Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Abortion Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Abortion Medication Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Abortion Medication Market Share by Country (2021-2026) Table 134. Asia-Pacific Abortion Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Abortion Medication Market Share Forecast by Country (2027-2032) Table 136. Latin America Abortion Medication Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Abortion Medication Sales by Country (2021-2026) & (k units) Table 138. Latin America Abortion Medication Sales Market Share by Country (2021-2026) Table 139. Latin America Abortion Medication Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Abortion Medication Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Abortion Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Abortion Medication Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Abortion Medication Market Share by Country (2021-2026) Table 144. Latin America Abortion Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Abortion Medication Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Abortion Medication Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Abortion Medication Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Abortion Medication Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Abortion Medication Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Abortion Medication Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Abortion Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Abortion Medication Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Abortion Medication Market Share by Country (2021-2026) Table 154. Middle East and Africa Abortion Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Abortion Medication Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Abortion Medication Distributors List Table 159. Abortion Medication Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Abortion Medication Image Figure 2. Global Abortion Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Abortion Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Abortion Medication Sales (2021-2032) & (k units) Figure 5. Mifepristone Image Figure 6. Global Mifepristone Sales YoY Growth (2021-2032) & (k units) Figure 7. Misoprostol Image Figure 8. Global Misoprostol Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Abortion Medication Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Abortion Medication Market Share by Type 2025 VS 2032 Figure 11. North America Abortion Medication Sales Market Share in Volume by Type in 2025 Figure 12. North America Abortion Medication Sales Market Share in Value by Type in 2025 Figure 13. Europe Abortion Medication Sales Market Share in Volume by Type in 2025 Figure 14. Europe Abortion Medication Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Abortion Medication Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Abortion Medication Sales Market Share in Value by Type in 2025 Figure 17. Latin America Abortion Medication Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Abortion Medication Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Abortion Medication Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Abortion Medication Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Abortion Medication Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinic Image Figure 24. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Abortion Medication Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Abortion Medication Market Share by Application 2025 VS 2032 Figure 31. North America Abortion Medication Sales Market Share in Volume by Application in 2025 Figure 32. North America Abortion Medication Sales Market Share in Value by Application in 2025 Figure 33. Europe Abortion Medication Sales Market Share in Volume by Application in 2025 Figure 34. Europe Abortion Medication Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Abortion Medication Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Abortion Medication Sales Market Share in Value by Application in 2025 Figure 37. Latin America Abortion Medication Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Abortion Medication Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Abortion Medication Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Abortion Medication Sales Market Share in Value by Application in 2025 Figure 41. North America Abortion Medication Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Abortion Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Abortion Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Abortion Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Abortion Medication Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Abortion Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Abortion Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Abortion Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Abortion Medication Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Abortion Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Abortion Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Abortion Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Abortion Medication Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Abortion Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Abortion Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Abortion Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Abortion Medication Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Abortion Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Abortion Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Abortion Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Abortion Medication Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Abortion Medication Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Mifepristone
  • Misoprostol
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Cadila
  • Cipla
  • Exelgyn Laboratories
  • GenBioPro
  • Zizhu-pharm
  • Shanghai Xinhualian Pharmaceutical Co., Ltd
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Abortion Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Abortion Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Abortion Medication Market by Type
  6. 1.3.1 Mifepristone
  7. 1.3.2 Misoprostol
  8. 1.4 Global Abortion Medication Market Size by Type
  9. 1.4.1 Global Abortion Medication Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Abortion Medication Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Abortion Medication Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Abortion Medication Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Abortion Medication Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Abortion Medication Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Abortion Medication Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Abortion Medication Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Abortion Medication Industry Trends
  2. 2.2 Abortion Medication Industry Drivers
  3. 2.3 Abortion Medication Industry Opportunities and Challenges
  4. 2.4 Abortion Medication Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Abortion Medication Revenue (2021-2026)
  2. 3.2 Global Top Players by Abortion Medication Sales (2021-2026)
  3. 3.3 Global Top Players by Abortion Medication Price (2021-2026)
  4. 3.4 Global Abortion Medication Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Abortion Medication Major Company Production Sites & Headquarters
  6. 3.6 Global Abortion Medication Company, Product Type & Application
  7. 3.7 Global Abortion Medication Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Abortion Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Abortion Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Abortion Medication Tier 1, Tier 2, and Tier 3
4 Abortion Medication Regional Status and Outlook
  1. 4.1 Global Abortion Medication Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Abortion Medication Historic Market Size by Region
  3. 4.2.1 Global Abortion Medication Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Abortion Medication Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Abortion Medication Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Abortion Medication Forecasted Market Size by Region
  7. 4.3.1 Global Abortion Medication Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Abortion Medication Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Abortion Medication Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Abortion Medication by Application
  1. 5.1 Abortion Medication Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Abortion Medication Market Size by Application
  6. 5.2.1 Global Abortion Medication Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Abortion Medication Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Abortion Medication Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Abortion Medication Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Abortion Medication Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Abortion Medication Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Abortion Medication Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Abortion Medication Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cadila
  2. 6.1.1 Cadila Company Information
  3. 6.1.2 Cadila Business Overview
  4. 6.1.3 Cadila Abortion Medication Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cadila Abortion Medication Product Portfolio
  6. 6.1.5 Cadila Recent Developments
  7. 6.2 Cipla
  8. 6.2.1 Cipla Company Information
  9. 6.2.2 Cipla Business Overview
  10. 6.2.3 Cipla Abortion Medication Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipla Abortion Medication Product Portfolio
  12. 6.2.5 Cipla Recent Developments
  13. 6.3 Exelgyn Laboratories
  14. 6.3.1 Exelgyn Laboratories Company Information
  15. 6.3.2 Exelgyn Laboratories Business Overview
  16. 6.3.3 Exelgyn Laboratories Abortion Medication Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Exelgyn Laboratories Abortion Medication Product Portfolio
  18. 6.3.5 Exelgyn Laboratories Recent Developments
  19. 6.4 GenBioPro
  20. 6.4.1 GenBioPro Company Information
  21. 6.4.2 GenBioPro Business Overview
  22. 6.4.3 GenBioPro Abortion Medication Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GenBioPro Abortion Medication Product Portfolio
  24. 6.4.5 GenBioPro Recent Developments
  25. 6.5 Zizhu-pharm
  26. 6.5.1 Zizhu-pharm Company Information
  27. 6.5.2 Zizhu-pharm Business Overview
  28. 6.5.3 Zizhu-pharm Abortion Medication Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zizhu-pharm Abortion Medication Product Portfolio
  30. 6.5.5 Zizhu-pharm Recent Developments
  31. 6.6 Shanghai Xinhualian Pharmaceutical Co., Ltd
  32. 6.6.1 Shanghai Xinhualian Pharmaceutical Co., Ltd Company Information
  33. 6.6.2 Shanghai Xinhualian Pharmaceutical Co., Ltd Business Overview
  34. 6.6.3 Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Product Portfolio
  36. 6.6.5 Shanghai Xinhualian Pharmaceutical Co., Ltd Recent Developments
  37. 6.7 Sun Pharma
  38. 6.7.1 Sun Pharma Company Information
  39. 6.7.2 Sun Pharma Business Overview
  40. 6.7.3 Sun Pharma Abortion Medication Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sun Pharma Abortion Medication Product Portfolio
  42. 6.7.5 Sun Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Abortion Medication Sales by Country
  2. 7.1.1 North America Abortion Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Abortion Medication Sales by Country (2021-2026)
  4. 7.1.3 North America Abortion Medication Sales Forecast by Country (2027-2032)
  5. 7.2 North America Abortion Medication Market Size by Country
  6. 7.2.1 North America Abortion Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Abortion Medication Market Size by Country (2021-2026)
  8. 7.2.3 North America Abortion Medication Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Abortion Medication Sales by Country
  2. 8.1.1 Europe Abortion Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Abortion Medication Sales by Country (2021-2026)
  4. 8.1.3 Europe Abortion Medication Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Abortion Medication Market Size by Country
  6. 8.2.1 Europe Abortion Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Abortion Medication Market Size by Country (2021-2026)
  8. 8.2.3 Europe Abortion Medication Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Abortion Medication Sales by Country
  2. 9.1.1 Asia-Pacific Abortion Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Abortion Medication Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Abortion Medication Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Abortion Medication Market Size by Country
  6. 9.2.1 Asia-Pacific Abortion Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Abortion Medication Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Abortion Medication Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Abortion Medication Sales by Country
  2. 10.1.1 South America Abortion Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Abortion Medication Sales by Country (2021-2026)
  4. 10.1.3 South America Abortion Medication Sales Forecast by Country (2027-2032)
  5. 10.2 South America Abortion Medication Market Size by Country
  6. 10.2.1 South America Abortion Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Abortion Medication Market Size by Country (2021-2026)
  8. 10.2.3 South America Abortion Medication Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Abortion Medication Sales by Country
  2. 11.1.1 Middle East and Africa Abortion Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Abortion Medication Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Abortion Medication Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Abortion Medication Market Size by Country
  6. 11.2.1 Middle East and Africa Abortion Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Abortion Medication Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Abortion Medication Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Abortion Medication Value Chain Analysis
  2. 12.1.1 Abortion Medication Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Abortion Medication Production Mode & Process
  7. 12.2 Abortion Medication Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Abortion Medication Distributors
  10. 12.2.3 Abortion Medication Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst